Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$494K Sell
10,081
-504
-5% -$23.5K 0.01% 581
2025
Q4
$381K Sell
10,585
-610
-5% -$24.7K ﹤0.01% 643
2025
Q3
$507K Sell
11,195
-456
-4% -$18.4K 0.01% 556
2025
Q2
$370K Buy
11,651
+3,750
+47% +$107K ﹤0.01% 620
2025
Q1
$236K Buy
+7,901
New +$278K ﹤0.01% 734
2024
Q4
Sell
-5,443
Closed -$220K 697
2024
Q3
$220K Buy
5,443
+475
+10% +$20.2K ﹤0.01% 616
2024
Q2
$232K Buy
+4,968
New +$218K ﹤0.01% 580
2021
Q1
Sell
-2,533
Closed -$203K 601
2020
Q4
$203K Buy
+2,533
New +$184K ﹤0.01% 556
2018
Q4
Sell
-3,799
Closed -$212K 448
2018
Q3
$212K Buy
+3,799
New +$195K 0.01% 452

Other funds holding CGNX

Fiduciary Trust's CGNX Position: Q1 2026 in Review

Fiduciary Trust reduced its Cognex (CGNX) stake by 4.8% in Q1 2026, selling an estimated $23.5K and leaving 10,081 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #581.

Fiduciary Trust first reported a position in CGNX in Q3 2018 and has held it in 9 quarters since. The position peaked at $507K in Q3 2025. 569 funds tracked by Wall St. Rank hold CGNX as of Q1 2026.

  • Fiduciary Trust held 10,081 shares of Cognex worth $494K as of Q1 2026.
  • Fiduciary Trust sold 504 Cognex shares in Q1 2026, an estimated $23.5K.
  • Cognex made up 0.01% of Fiduciary Trust's portfolio in Q1 2026, its #581 holding.
  • Fiduciary Trust first reported a position in Cognex in Q3 2018 and has held it in 9 quarters since.
  • Fiduciary Trust's Cognex position peaked at $507K in Q3 2025.
  • 569 funds tracked by Wall St. Rank held Cognex as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.